BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 22112490)

  • 1. Renal cell carcinoma.
    Cairns P
    Cancer Biomark; 2010; 9(1-6):461-73. PubMed ID: 22112490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
    Maher ER
    World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide promoter methylome of small renal masses.
    Ibragimova I; Slifker MJ; Maradeo ME; Banumathy G; Dulaimi E; Uzzo RG; Cairns P
    PLoS One; 2013; 8(10):e77309. PubMed ID: 24204800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study.
    Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Matin SF; Karam JA; Huang M; Chang DW; Wood CG; Wu X
    Clin Cancer Res; 2016 Apr; 22(8):2074-82. PubMed ID: 26655847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma: basic biology and clinical behavior.
    Franklin JR; Figlin R; Belldegrun A
    Semin Urol Oncol; 1996 Nov; 14(4):208-15. PubMed ID: 8946619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Analysis Reveals the Important Role of the
    Lai YC; Wang WC
    Anticancer Res; 2021 Sep; 41(9):4295-4304. PubMed ID: 34475049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
    Yap NY; Yap FN; Perumal K; Rajandram R
    Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
    [No Abstract]   [Full Text] [Related]  

  • 8. RCDB: Renal Cancer Gene Database.
    Ramana J
    BMC Res Notes; 2012 May; 5():246. PubMed ID: 22608002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications.
    Li M; Wang Y; Cheng L; Niu W; Zhao G; Raju JK; Huo J; Wu B; Yin B; Song Y; Bu R
    Oncotarget; 2017 Jul; 8(29):48424-48435. PubMed ID: 28467794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
    Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
    Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
    Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI
    Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and Kidney Cancer.
    Wilson KM; Cho E
    Recent Results Cancer Res; 2016; 208():81-93. PubMed ID: 27909903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic kidney cancer syndromes.
    Ho TH; Jonasch E
    J Natl Compr Canc Netw; 2014 Sep; 12(9):1347-55. PubMed ID: 25190700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic alterations during renal carcinogenesis.
    Arai E; Kanai Y
    Int J Clin Exp Pathol; 2010 Dec; 4(1):58-73. PubMed ID: 21228928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal cell carcinoma in Iceland].
    Thoroddsen A; Einarsson GV; Gudbjartsson T
    Laeknabladid; 2007 Apr; 93(4):283-97. PubMed ID: 17460340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests.
    Kubiliute R; Jarmalaite S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.
    Awakura Y; Nakamura E; Takahashi T; Kotani H; Mikami Y; Kadowaki T; Myoumoto A; Akiyama H; Ito N; Kamoto T; Manabe T; Nobumasa H; Tsujimoto G; Ogawa O
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1363-9. PubMed ID: 18483744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.